Post-stripping sclerodermiform dermatitis.

Post-stripping sclerodermiform dermatitis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Post-stripping sclerodermiform dermatitis. Abstract Text:

BACKGROUND: Cutaneous sclerosis, a process that results in hardening of the skin, is the hallmark of scleroderma and sclerodermoid disorders. Cutaneous sclerosis is usually classified as secondary or primary, depending on the presence or absence of underlying diseases. Primary cutaneous sclerosis is a feature of idiopathic inflammatory processes that are often associated with autoimmune disorders, whereas secondary cutaneous sclerosis arises in the context of many pathological processes of varying causes, including chronic graft-vs-host disease, defined metabolic or genetic disorders, and exposure to certain infectious organisms, drugs, or chemicals. OBSERVATIONS: Three patients had localized cutaneous sclerosis overlying the site of a surgically removed (stripped) great saphenous vein. In all 3 patients, lesions were clinically characterized by multiple hypopigmented and indurated plaques distributed linearly along the path of the preexisting vein. Extensive history, physical examination, and diagnostic tests did not reveal known predisposing factors for cutaneous sclerosis. CONCLUSIONS: Although the observed association of sclerodermiform dermatitis and venous stripping in these 3 patients does not imply a causal relationship, the absence of other identifiable predisposing factors and the striking linear distribution of the cutaneous lesions along the path of the preexisting vein are suggestive. This poststripping sclerodermiform dermatitis may be a rare late complication of saphenous vein stripping.

Post-stripping sclerodermiform dermatitis. Publishing Authors By Initials

For similar cardiovascular diseases: vascular diseases: varicose veins research abstracts see: cardiovascular diseases: vascular diseases: varicose veins research

PUBMED ID PMID:

MEDLINE DATE:

Post-stripping sclerodermiform dermatitis. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Archives of dermatology

VOLUME: 135

Page Numbers: 1387-91

Journal Abbreviation: Arch Dermatol

ISSN: 0003-987X

DAY: 17

MONTH: Nov

YEAR: 1999

Post-stripping sclerodermiform dermatitis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 372433

Post-stripping sclerodermiform dermatitis. Keywords Mesh Terms:

KEYWORDS: Varicose Veins

MESH TERMS: therapy

Chemical & Substance for Abstract: Post-stripping sclerodermiform dermatitis. Information

Substance Name: polidocanol

Registry Number: 9002-92-0

Grant and Affiliation Information for Post-stripping sclerodermiform dermatitis.

AFFILIATION: Department Hospitalo-Universitaire Romand de Dermatologie Geneva/Lausanne, Geneva, Switzerland. french@cmu.unige.ch

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Arch Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Post-stripping sclerodermiform dermatitis Related Publications

• Adults with atopic dermatitis and herpes simplex and topical therapy with tacrolimus: what kind of prevention?
• Allergic contact dermatitis to carboxymethylcellulose in Comfeel((R)) hydrocolloid dressing.
• B-cell lymphoma after cyclosporine for keratosis lichenoides chronica.
• Commentary 1.
• Erosive pustular dermatosis of the scalp: treatment with topical tacrolimus.
• Frequency of bullous pemphigoid-like antibodies as detected by western immunoblot analysis in pruritic dermatoses.
• Histopathologic correlation in dermoscopy: a micropunch technique.
• Hyaluronate fragments reverse skin atrophy by a CD44-dependent mechanism.
• IgM autoantibodies to 180- and 230- to 240-kd human epidermal proteins in pregnancy.
• Infliximab then efalizumab, the 'hit and run' approach does not work.
• Long-term control with etanercept (Enbrel) of a severe acrodermatitis continua of Hallopeau refractory to infliximab (Remicade).
• Management of psoriasis: the position of retinoid drugs.
• Metabolism and biological activities of topical 4-oxoretinoids in mouse skin.
• Neutrophilic Cutaneous Lupus Erythematosus. At the Edge between Innate and Acquired Immunity?
• Plasma and skin carriers for natural and synthetic retinoids.
• Post-stripping sclerodermiform dermatitis.
• Proposed mechanisms of action for retinoid derivatives in the treatment of skin aging.
• Recommendations for the long-term treatment of psoriasis with infliximab: a dermatology expert group consensus.
• Specific dermatoses of pregnancy. Toward a comprehensive view?
• The "wobble sign" in epiluminescence microscopy as a novel clue to the differential diagnosis of pigmented skin lesions.